-
Rumors, Expectations Surround Apple Expansion Into Health Care
POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.
Oct 5, 2016
-
Gene Editing Takes the Stage at Discovery on Target 2016
Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.
Oct 4, 2016
-
Azure is becoming the first AI supercomputer says Microsoft
ZDNet | Microsoft's CEO on how its cloud computing service is evolving.
Oct 4, 2016
-
Biotech PR Needs to Deliver More Signal Less Noise
Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.
Oct 4, 2016
-
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.
Oct 3, 2016
-
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
Sep 29, 2016
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.
Sep 29, 2016
-
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
Sep 29, 2016
-
Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval
MIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Sep 29, 2016
-
Why Big Pharma Wants To Collect 2 Million Genomes
Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.
Sep 28, 2016
-
Microsoft Goes All in for FPGAs to Build Out AI Cloud
TOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."
Sep 28, 2016
-
Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target
Bio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.
Sep 28, 2016
-
Color Genomics Raises $45 Million To Expand Genetic Testing
Bloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.
Sep 27, 2016
-
Kite Unveils Anticipated CAR-T Cancer Data Positive But Not Complete
Xconomy | Kite Pharma has dipped into a highly anticipated clinical trial of its cancer treatment, KTE-C19, to release a partial set of data. Although not complete, the data bolster the view that Kite could be the first among its peers to win the FDA's green light.
Sep 27, 2016
-
The Sequencing App and the Quest for Fun
Bio-IT World | The latest way to get into your genome is a $50 app-based venture that promises to give you a peek into your ancestry and tell you what kinds of bacteria you’re harboring in your mouth. Seeq launched earlier this month offering ultra-low coverage sequencing of the genome, oral microbiome sequencing, and ancestry reports. The goal is an extremely inexpensive infrastructure for people to get a little bit of genomic data and participate in research in a way that’s easy and fun.
Sep 26, 2016
-
Top Scientists Cautious About Curing Cancer With Immunotherapy
STAT | There's been a lot of excitement about immunotherapy as a tool to treat cancer. But top experts on Sunday struck an unexpected note of caution.
Sep 26, 2016
-
New Genomics Pipeline Combines AWS, Local HPC, and Supercomputing
HPCwire | Declining DNA sequencing costs and the rush to do whole genome sequencing (WGS) of large cohort populations presents an infrastructure challenge that some researchers are solving with a hybrid approach.
Sep 23, 2016
-
When “Actionable” Genomic Sequencing Results Cannot Be Acted Upon
JAMA Oncology | Brian J. Zikmund-Fisher recounts an interaction he had with a participant involved in genomic sequencing, in which the term “actionable” led to false hope and dashed expectations.
Sep 23, 2016
-
Gilead Allergan Seen Trailing Intercept In Ongoing NASH Battle
Investor's Business Daily | Gilead is trailing Intercept in the battle against NASH, Credit Suisse analyst Alethia Young said Thursday, two days after Botox maker Allergan jumped in.
Sep 23, 2016
-
Chan Zuckerberg Initiative Lays Out Plan For Funding Disease Research
Bio-IT World | The Chan Zuckerberg Initiative took to Facebook Live yesterday to lay out their plan of funding the Initiative’s first project. The project, a Biohub located in San Francisco, will combine the knowledge of renowned scientists and engineers in the pursuit of curing disease.
Sep 22, 2016